InvestorsHub Logo
icon url

jour_trader

04/05/17 6:49 PM

#249808 RE: Couch #249805

The FDA is privy to much more data than the public shareholder. Until we actually get an Adcom meeting, when more data becomes available, we will have more insight. Remember, it wasn't until we received the CRL that there was a risk of overdose under fed fatty meal conditions. On that same premise, what else do we not know about?